Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Milla Pharmaceuticals Inc.
A.forall Announces ANDA Approval for Sodium Bicarbonate for Injection, USP
July 13, 2026
From
Milla Pharmaceuticals Inc.
Via
Business Wire
A.forall Announces the Direct Commercialization of Sodium Acetate Injection 2mEq/mL
July 22, 2025
From
Milla Pharmaceuticals Inc.
Via
Business Wire
A.forall Announces the Launch of Their Fifth Abbreviated New Drug Application (ANDA) and Second “First Cycle” FDA Approval
July 25, 2024
From
Milla Pharmaceuticals Inc.
Via
Business Wire
A.forall Announces Launch of a Generic Version of Sodium Acetate Injection 4 mEq/mL
January 09, 2024
From
Milla Pharmaceuticals Inc.
Via
Business Wire
A.forall Announces Launch of a Generic Version of Pyridostigmine Bromide Syrup
December 11, 2023
From
Milla Pharmaceuticals Inc.
Via
Business Wire
The Alter Pharma Group is Becoming A.forall
September 27, 2023
From
Milla Pharmaceuticals Inc.
Via
Business Wire
Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce Yet Another “First Cycle” FDA Approval for an Abbreviated New Drug Application (ANDA), Dexmedetomidine Hydrochloride Injection
June 09, 2023
From
Milla Pharmaceuticals Inc.
Via
Business Wire
Milla Pharmaceuticals Inc. and the Alter Pharma Group Announce Launch of a Generic Version of Magnesium Sulfate in Water for Injection, in Non-PVC, Single-Patient Use Containers by Their Partner Athenex Pharmaceutical Division (APD)
March 20, 2023
From
Milla Pharmaceuticals Inc.
Via
Business Wire
Third ANDA Approval for Milla Pharmaceuticals Inc. and the 4th U.S. Approval for the Alter Pharma Group.
April 19, 2022
From
Milla Pharmaceuticals Inc.
Via
Business Wire
Milla Pharmaceuticals Inc. Announces Approval of a Generic Version of Magnesium Sulfate in Water for Injection, in Non-PVC, Single-Patient Use Containers
November 09, 2021
From
Milla Pharmaceuticals Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at
/week.
Subscribe Today